Retail Offer Oversubscribed

Not for release or distribution in the United States
12 May 2025
NZX / ASX Code: EBO
RETAIL OFFER OVERSUBCRIBED
EBOS Group Limited (“EBOS”) is pleased to announce that its up to A$50 million (NZ$54 million
1
)
retail offer (“Retail Offer”) has closed oversubscribed. The Retail Offer was strongly supported by
eligible shareholders, with EBOS receiving valid applications totalling approximately A$54 million
(NZ$58 million
2
).
In recognition of the support from retail shareholders, EBOS has elected to increase the size of the
Retail Offer to accept all valid applications from retail shareholders, bringing the total amount raised
under the Retail Offer to A$54 million (NZ$58 million
2
).
A total of approximately 1.6 million new fully paid EBOS ordinary shares will be issued under the
Retail Offer at the issue price of NZ$36.65 or A$33.92
2
per share.
Under the Retail Offer, each person who was recorded in EBOS’ share register as being a registered
holder of EBOS ordinary shares and having an address in New Zealand or Australia as at 7:00pm
(NZST) / 5:00pm (AEST) on the record date of Wednesday, 9 April 2025 (“Eligible Shareholders”)
could subscribe for up to NZ$100,000 / A$45,000, respectively, of new EBOS shares. 12,262 Eligible
Shareholders applied under the Retail Offer, with an average application size of approximately
NZ$4,746.
The Retail Offer was part of EBOS’ equity raising announced on Thursday, 10 April 2025, pursuant to
which EBOS also undertook a fully underwritten placement of new shares to raise approximately
A$200 million (NZ$217 million
1
) to fund the acquisition of SVS and remaining 10% stake in
Transmedic as well as providing balance sheet capacity.
Settlement of the Retail Offer and allotment of the new shares issued under the Retail Offer is
expected to occur on Tuesday, 13 May 2025, with NZX trading in the new shares expected to
commence on the same day and ASX trading in the new shares expected to commence on
Wednesday, 14 May 2025. The new shares will rank equally with existing EBOS ordinary shares on
issue.
Authorised for lodgement with NZX and ASX by:
Janelle Cain
General Counsel
EBOS Group Limited
+ 61 3 9918 5555

1
Based on an A$:NZ$ exchange rate of 1.0861 as at 10 April 2025.
2
Based on the A$:NZ$ exchange rate as published by the Reserve Bank of Australia on its website at 4:00pm AEST / 6:00pm
NZST on the Retail Offer close date of Tuesday, 6 May 2025, being 1.0805.

ABOUT EBOS GROUP
EBOS Group Limited NZBN 9429031998840 (NZX/ASX Code: EBO) is the largest and most diversified
Australasian marketer, wholesaler and distributor of healthcare, medical and pharmaceutical
products. It is also a leading Australasian animal care brand owner, product marketer and distributor.
NOT FOR RELEASE OR DISTRIBUTION IN THE UNITED STATES
This market release has been prepared for publication in Australia and New Zealand and may not be
released or distributed in the United States. This market release does not constitute an offer to sell,
or a solicitation of an offer to buy, any securities in the United States or any other jurisdiction in
which such an offer would be illegal. The securities referred to in this release have not been, and will
not be, registered under the US Securities Act of 1933 as amended (the “US Securities Act”) or the
securities laws of any state or other jurisdiction of the United States and may not be offered or sold,
directly or indirectly, in the United States or to persons acting for the account or benefit of a person
in the United States except in transactions exempt from, or not subject to, the registration
requirements of the US Securities Act and the securities laws of any state or other jurisdiction of the
United States. The securities to be offered and sold in the Retail Offer may only be offered and sold
to persons that are not in the United States and are not acting for the account or benefit of a person
in the United States, in each case in “offshore transactions” (as defined in Rule 902(h) under the US
Securities Act) in reliance on Regulation S under the US Securities Act.
You must not send copies of this announcement or any other material relating to the Retail Offer to
any person in the United States or elsewhere outside Australia and New Zealand. The release,
publication or distribution of this announcement (including an electronic copy) outside New Zealand
or Australia may be restricted by law. If you come into possession of this announcement, you should
observe such restrictions. Any non-compliance with these restrictions may contravene applicable
securities laws.